{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:30:53Z","timestamp":1792459853822,"version":"4.5.0"},"reference-count":16,"publisher":"Informa Healthcare","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2010,2,1]]},"DOI":"10.1185\/03007990903479299","type":"journal-article","created":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T13:28:23Z","timestamp":1259933303000},"page":"307-317","source":"Crossref","is-referenced-by-count":22,"title":["Management of chronic myeloid leukaemia in clinical practice in France: results of the French subset of patients from the UNIC study"],"prefix":"10.1185","volume":"26","author":[{"given":"Mauricette","family":"Michallet","sequence":"first","affiliation":[{"name":"Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Tulliez","sequence":"additional","affiliation":[{"name":"H\u00f4pital Henri Mondor, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9lim","family":"Corm","sequence":"additional","affiliation":[{"name":"H\u00f4pital Claude Huriez, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Gardembas","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Huguet","sequence":"additional","affiliation":[{"name":"CHU Purpan, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderrahim","family":"Oukessou","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb, Rueil-Malmaison, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Bregman","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb, Rueil-Malmaison, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vekhoff","sequence":"additional","affiliation":[{"name":"H\u00f4pital H\u00f4tel Dieu, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Ghomari","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Beauvais, Beauvais, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cambier","sequence":"additional","affiliation":[{"name":"H\u00f4pital Saint Vincent, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Guerci-Bresler","sequence":"additional","affiliation":[{"name":"CHU Brabois, Vandoeuvre les Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1038\/243290a0"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1038\/315550a0"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-005686"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Baccarani M, Cortes J, Pane F, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009: published online 2 November 2009, doi: 10.1200\/JCO.2009.25.0779","DOI":"10.1200\/JCO.2009.25.0779"},{"key":"CIT0006","doi-asserted-by":"crossref","unstructured":"Guilhot F. Sustained durability of responses plus high rates of cytogenetic responses result in long-term benefit for newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP) treated with imatinib (IM) therapy: update from the IRIS study. Blood 2004;104: Abstract 21","DOI":"10.1182\/blood.V104.11.21.21"},{"key":"CIT0007","doi-asserted-by":"crossref","unstructured":"Silver RT, Talpaz M, Sawyers CL, et al. Four years of follow-up of 1027 patients with late chronic phase (L-CP), accelerated phase (AP), or blast crisis (BC) chronic myeloid leukemia (CML) treated with imatinib in three large Phase II trials. Blood 2004;104: Abstract 23","DOI":"10.1182\/blood.V104.11.23.23"},{"key":"CIT0008","first-page":"1248","volume":"9","author":"Marcucci G","year":"2003","journal-title":"Clin Cancer Res"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2004.03.001"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-103523"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1046"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Corm S, Leroyer A, Wemeau M, et al. A retrospective 20-year survey of the incidence of chronic myeloid leukemia in the Northern France region. In: American Society of Hematology, Orlando, FL, USA, 2006","DOI":"10.1182\/blood.V108.11.4798.4798"},{"key":"CIT0013","doi-asserted-by":"crossref","unstructured":"Michallet M, Morra E, Steegmann JL, et al. Imatinib resistance and\/or intolerance in clinical practice in Europe: The Unmet Needs in CML and Ph+ALL (UNIC) study. Blood (ASH Annual Meeting Abstracts) 2007;110: Abstract 1951","DOI":"10.1182\/blood.V110.11.1951.1951"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Morra E, Mauricette M, Steegmann JL, et al. Real-life rates of disease monitoring in clinical practice in Europe: The Unmet Needs in CML and Ph+ALL (UNIC) study. Blood (ASH Annual Meeting Abstracts) 2007;110: Abstract 1959","DOI":"10.1182\/blood.V110.11.1959.1959"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011573"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.8154"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007990903479299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T11:11:27Z","timestamp":1599304287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007990903479299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2,1]]}},"alternative-id":["10.1185\/03007990903479299"],"URL":"https:\/\/doi.org\/10.1185\/03007990903479299","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,4]]}}}